Evidence map›Paper›PMID 40024885›Full record

ArticleJournal of diabetes2025

Association Between Skin Autofluorescence and Coronary Heart Disease in Chinese General Population: A Cross-Sectional Study.

Qingzheng Wu, Yu Cheng, Hongyan Liu, Yuepeng Wang, Bing Li, Yiming Mu

Abstract read
In one paragraph

Article in Journal of diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qingzheng WuDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.ORCID https://orcid.org/0009-0008-4327-7313
Yu ChengDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Hongyan LiuDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Yuepeng WangDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-5031-9664
Bing LiDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-1510-3227
Yiming MuDepartment of Endocrinology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-3344-3540

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to investigate the relationship between SAF and CHD in the general population of China and to assess the feasibility of SAF used as a predictor of CHD.

methodsThis study was nested within the prospective study REACTION (Cancer Risk Assessment in Chinese Diabetic Population) which included a total of 5806 eligible participants from two communities located in urban Beijing in 2018. SAF were measured using a fluorescence detector (DM Scan). CHD was the study endpoint and was determined by a face-to-face clinical survey. Pearson's correlation analysis, linear regression analysis, and binary logistic regression analysis were used to examine the association between SAF and CHD.

resultsThe overall prevalence of CHD in the general population was 12.1%. Logistic analysis showed that after full adjustment for confounding factors, the risk of CHD increased significantly with increasing lnSAF quartiles (p-trend < 0.05). Compared to Q1 group, the multivariate adjusted ORs of Q2 and Q3 groups were 1.071 (0.817, 1.404), 1.025 (0.781, 1.344), respectively, and the OR was markedly increased at Q4 (OR = 1.377 [1.043, 1.817]). When lnSAF was a continuous variable, the risk of CHD increased with the elevation of lnSAF level. Stratified analysis showed that in subgroups with overweight (24-28 kg/m

conclusionsIn Chinese general population, higher lnSAF is independently associated with increased risk of CHD, and noninvasive SAF holds the potential to be a biomarker for CHD risk evaluation and stratification.

Indexed as

Coronary DiseaseOptical ImagingSkinAdultAgedChinaCross-Sectional StudiesEast Asian PeopleFemaleFluorescenceHumansMaleMiddle AgedPrevalenceProspective StudiesRisk Assessmentadvanced glycation end productscoronary heart diseaseREACTION studyskin autofluorescence

Identifiers

PMID40024885
PMCPMC11872386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.